Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23

Merck’s oral cholesterol-lowering drug shows similar efficacy to injectable predecessors as it moves to PhIII: #ACC23

Source: 
Endpoints
snippet: 

In back-to-back presentations on Monday with its Phase III data on a drug for pulmonary arterial hypertension, Merck unveiled new mid-stage data on an oral cholesterol-lowering drug for heart disease.